ResMed Inc.: A Story Of Increased Market Penetration and New Patient Acquisition!

ResMed recently reported its fourth quarter results for the fiscal year 2024, providing a comprehensive update on its performance across various business segments. The company demonstrated robust growth attributed to increased demand and operational excellence, with a focus on innovations in sleep apnea, digital health solutions, and home medical equipment software. Financially, ResMed achieved a 9% increase in revenue year-over-year, amounting to $1.22 billion for the quarter. The increase was seen both on home turf and internationally, with the U.S., Canada, and Latin America up by 10% and Europe, Asia, and other markets growing by 8%. This growth is supported by strong sales in both device and mask categories. Notably, device sales saw a 6% increase globally, driven by continuous demand for the AirSense 11 platform, while mask sales surged by 15%, benefiting from the new AirFit F40 mask’s market introduction.